You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tuberculosis treatment shortening

Showing 1 - 25 of 1,522
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tuberculosis, Pulmonary Trial (Sitafloxacin, SMZ/TMP, Rifampin)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • (no location specified)
Jul 7, 2022

Tuberculosis, Pulmonary Trial in China (Short Regimen with Rifapentine 10mg/kg, Standardized Regimen, Short Regimen with

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Short Regimen with Rifapentine 10mg/kg
  • +3 more
  • Guiyang, Guizhou, China
  • +5 more
May 28, 2022

Tuberculosis, Pulmonary, Tuberculosis Infection Trial in Worldwide (Rifabutin, Delamanid, Bedaquiline)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Tuberculosis Infection
  • Denver, Colorado
  • +14 more
Mar 2, 2023

Tuberculosis Trial in Worldwide (rifapentine, rifapentine and moxifloxacin, control)

Completed
Has Results
  • Tuberculosis
  • San Francisco, California
  • +32 more
Sep 1, 2021

Tuberculosis, Pulmonary Trial in Seoul (High-dose rifampicin, Isoniazid, Pyrazinamide)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • High-dose rifampicin
  • +4 more
  • Seoul, Korea, Republic of
    Division of Pulmonology and Critical Care Medicine, Department o
Jul 21, 2020

Tuberculosis, Pulmonary, HIV Trial in Port-au-Prince, Cape Town (Bedaquiline, Clofazimine, Pyrazinamide)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • HIV
  • Port-au-Prince, Haiti
  • +1 more
Nov 11, 2022

Tuberculosis, Pulmonary Trial in Houston (Azacitidine Injection)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Azacitidine Injection
  • Houston, Texas
    Harris Health System - Ben Taub Hospital
Sep 1, 2022

MDR-TB Trial in Worldwide (Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Clofazimine)

Active, not recruiting
  • MDR-TB
  • Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline)
  • +9 more
  • Addis Ababa, Ethiopia
  • +12 more
Oct 12, 2022

Buruli Ulcer Trial in Allada, Lalo, Pobè (Standard [RC8]: rifampicin plus clarithromycin (RC) therapy for 8 weeks.,

Recruiting
  • Buruli Ulcer
  • Standard [RC8]: rifampicin plus clarithromycin (RC) therapy for 8 weeks.
  • Investigational [RCA4]: standard (RC) plus amoxicillin/clavulanate (A) for 4 weeks.
  • Allada, Benin
  • +2 more
Dec 22, 2021

Tuberculosis Trial in Cape Town (Xpert Ultra Point of Care testing)

Completed
  • Tuberculosis
  • Xpert Ultra Point of Care testing
  • Cape Town, Western Cape, South Africa
  • +1 more
Nov 1, 2022

Tuberculosis, Pulmonary Tuberculosis, HIV Coinfection Trial in Johannesburg (Isoniazid, Rifampicin, Ethambutol)

Recruiting
  • Tuberculosis
  • +2 more
  • Johannesburg, Gauteng, South Africa
    Tembisa Clinical Research Centre-The Aurum Institute
Jun 8, 2022

MDR-TB Trial in Shanghai (PRS Regimen V, MDR-TB Treatment Regimen(WHO))

Recruiting
  • MDR-TB
  • PRS Regimen V
  • MDR-TB Treatment Regimen(WHO)
  • Shanghai, China
    Shanghai Pulmonary Hospital
Aug 4, 2022

Tuberculosis Trial in Vitória, Makati, Kampala (Ethambutol, Isoniazid, Pyrazinamide)

Completed
Has Results
  • Tuberculosis
  • Vitória, Espírito Santo, Brazil
  • +2 more
Oct 11, 2018

Tuberculosis, Multidrug-Resistant Trial in Seoul (Linezolid, Delamanid, Levofloxacin)

Unknown status
  • Tuberculosis, Multidrug-Resistant
  • Seoul, Korea, Republic of
    Division of Pulmonology and Critical Care Medicine, Department o
Jan 31, 2019

Hospitalized Pulmonary Tuberculosis at Strasbourg University

Recruiting
  • Pulmonary Tuberculosis
    • Strasbourg, France
      Centre de Ressources et de Compétences de la Mucoviscidose (CRCM
    Oct 25, 2023

    BAriatric Surgery Induced Chromosomal Change

    Not yet recruiting
    • Obesity, Morbid
      • Weston, Florida
        Cleveland Clinic Florida
      Jun 15, 2023

      Tuberculosis, Severe Pneumonia, Covid19 Trial in Worldwide (Xpert MTB/RIF Ultra (Ultra))

      Completed
      • Tuberculosis
      • +2 more
      • Xpert MTB/RIF Ultra (Ultra)
      • Kampong Cham, Cambodia
      • +14 more
      Oct 27, 2021

      Tuberculosis, Post-Tuberculous Pleural Fibrosis, Post-Tuberculous Bronchiectasis Trial in Peshawar (Experimental, Control)

      Recruiting
      • Tuberculosis
      • +2 more
      • Experimental
      • Control
      • Peshawar, KPK, Pakistan
        Green Star NGO
      Sep 14, 2023

      Tuberculosis, Latent Tuberculosis Infection Trial in Bijie, Linping, Qingzhen (QuantiFERON-TB Gold (QFT) test)

      Recruiting
      • Tuberculosis
      • Latent Tuberculosis Infection
      • QuantiFERON-TB Gold (QFT) test
      • Bijie, Guizhou, China
      • +4 more
      Sep 12, 2023

      Tuberculosis Trial in Bandung (moxifloxacin)

      Completed
      • Tuberculosis
      • Bandung, Indonesia
        Rumah Sakit Hasan Sadikin (RSHS)
      Nov 9, 2020

      KAP Regarding Tuberculosis Among Physicians in Assiut City

      Not yet recruiting
      • Tuberculosis
        • (no location specified)
        Apr 6, 2023

        Tuberculosis, Pulmonary, Drug Sensitive, Tuberculosis, Pulmonary, Multi Drug-resistant Trial in Worldwide (Moxifloxacin, PA-824,

        Completed
        Has Results
        • Tuberculosis, Pulmonary, Drug Sensitive
        • Tuberculosis, Pulmonary, Multi Drug-resistant
        • Tbilisi, Georgia
        • +25 more
        Mar 1, 2019

        Tuberculosis Trial in Shanghai, Hangzhou (Short-course regimen, Standard regimen)

        Active, not recruiting
        • Tuberculosis
        • Short-course regimen
        • Standard regimen
        • Shanghai, Shanghai, China
        • +1 more
        Nov 22, 2023

        Sensitivity and Specificity of Xpert MTB/RIF Ultra

        Not yet recruiting
        • Tuberculosis
          • (no location specified)
          Oct 1, 2023

          COPD Trial (previous pulmonary tuberculosis)

          Not yet recruiting
          • COPD
          • previous pulmonary tuberculosis
          • (no location specified)
          Oct 5, 2023